Skip to search formSkip to main contentSkip to account menu

stage II non-small cell lung cancer

Known as: Stage II Non-Small Cell Carcinoma of the Lung, stage II nonsmall cell lung cancer, lung cancer, non-oat cell, stage II 
Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0). T2b: Lung cancer with a tumor… 
National Institutes of Health

Related topics

Related topics

15 relations
ChestEGFR Gene MutationEGFR geneEpithelial Cells

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Poster ViewingSBRT for Stage II NSCLC: An Analysis of the National Cancer Database
2014
2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in…
2012
2012
Lung cancer in Berlin - Therapeutic concepts and their impact on survival in patients with NSCLC stage II/III from 2000 to 2008
Backgroud: The Tumorzentrum Berlin (TZB) amalgamates the clinical data of lung cancer pts. in order to improve pt. care by means… 
2011
2011
Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer (NSCLC).
7067 Background: Evidence-based guidelines recommend chemotherapy for medically fit NSCLC stage II-IV patients. Understanding the… 
Review
2010
Review
2010
Adjuvant therapy in early-stage non-small cell lung cancer.
Evidence clearly supports adjuvant chemotherapy following resection in patients with stage II or III non-small cell lung cancer… 
2007
2007
Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study.
BACKGROUND The aim of this study was to determine the overall survival, progression-free survival, and toxicity associated with… 
2007
2007
The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
2004
2004
Vinorelbine (NVB)-based triplet with ifosfamide (IFO) and cisplatin (NIP) as induction chemotherapy (CT) to increase resection rate in marginally unresectable non-small cell lung cancer (NSCLC…
7165 Background: Combined strategy CT+surgery is currently considered the best option treatment for pts with locally advanced (LA… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)